Manufacturing news briefs – stories you might have missed

Orthocell grants licence for bone regeneration in dental implant market Bone and tissue regeneration company Orthocell has signed a global exclusive licence and manufacturing agreement for its Striate+ resorbable collagen membrane product with leading dental implant company BioHorizons Implant Systems. In consideration for the licence, BioHorizons will pay Orthocell $23.1 million. Orthocell will supply BioHorizons…

Manufacturing news briefs – stories you might have missed

LGP to enter psychedelics market Cannabis producer Little Green Pharma has been granted a Schedule 9 licence by the Western Australian Department of Health to supply the psychedelic psilocybin to treat mental illness. LGB has established a special purpose subsidiary for psychedelic business which is planning to manufacture psilocybin in WA and conduct clinical trials.…

CelGro uses extended to treating lymphedema

Tissue regeneration technology developer Orthocell’s CellGro collagen tissue regeneration scaffolds may be useful in treating the limb swelling caused by lymphedema, a condition for which there is no known cure. The company announced research published in proceedings of the National Academy of Sciences of the United States (PNAS) which suggests that combining CelGro with lymphatic…

Manufacturing news briefs – stories you might have missed

Electrolux manufactures 6.5 millionth oven Adelaide whitegoods manufacturer Electrolux has celebrated building its 6.5 millionth oven at its factory in Simpson Avenue, Dudley Park. Head of commercial Tony Hinchco said: “Congratulations to everyone involved from the Australian based designers and product development team who dream up our products to the engineers and manufacturing teams who…

CelGro Dental recommended for prosthesis list

Tissue regeneration technology developer Orthocell’s CelGro Dental product has been recommended for inclusion on the Australian Prosthesis List, opening opportunities for Australian and international sales. The list defines the benefit to be paid by private health insurers for the CelGro product. The Perth company is commercialising products to facilitate the regeneration of severed peripheral nerves…